There was an increased proportion of IL-21 expressing CD8+ T-cells in active SLE patients as compared to HC (3.8 ± 3.6% vs. 1.5 ± 1.1%, P = 0.04, Figure 2D). The gene discussed is IL21; the disease is systemic lupus erythematosus.